InMed Pharmaceuticals Inc. (MTRI) stock
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$18.35+2.74 (+17.56%)
Close on Nov 12, 2026Market cap $100.81MP/E –Yield –
InMed Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
InMed Pharmaceuticals's enterprise value was $6.77M on Nov 3, 2026, against -$5.94M a year earlier. Over the last 5 years it ranged from -$9.78M to $6.77M, with a median of -$4.49M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $6.77M | – |
| 2025 | Dec 31, 2025 | -$6.64M | – |
| 2024 | Dec 31, 2024 | -$2.44M | – |
| 2023 | Dec 29, 2023 | -$5.42M | – |
| 2022 | Dec 30, 2022 | -$7.56M | – |
| 2021 | Dec 31, 2021 | -$1.86M | -114.7% |
| 2020 | Dec 31, 2020 | $12.63M | – |
See a number that looks wrong?